Tweets: ACHN (Achillion Pharmaceuticals)

zbiotech via Twitter 09:52 PM  05/23/13 reply  |  re-tweet

@johntuckerphd @JasonCRG @genefj $ACHN (Msgs, Twts) will have arms both w/and w/o riba...8 and 12 wks, rash not a class effect of PIs

JasonCRG via Twitter 08:29 PM  05/23/13 reply  |  re-tweet

@genefj @zbiotech don't think $ACHN (Msgs, Twts) will have riba- any guess as to how they will stack up?

The_Squibb via Twitter 10:22 AM  05/23/13 reply  |  re-tweet

RT @zbiotech: $MRK (Msgs, Twts) PI/NS5a pII completed enrollment, SVR12 poss at AASLD tho prob tight, read-thru to $ACHN (Msgs, Twts), catalyst for '14 vol http://t.co/aPmNFRJwH8

jorgepalacios01 via Twitter 10:15 AM  05/23/13 reply  |  re-tweet

RT @zbiotech: $MRK (Msgs, Twts) PI/NS5a pII completed enrollment, SVR12 poss at AASLD tho prob tight, read-thru to $ACHN (Msgs, Twts), catalyst for '14 vol http://t.co/aPmNFRJwH8

natesadeghi via Twitter 10:12 AM  05/23/13 reply  |  re-tweet

RT @zbiotech: $MRK (Msgs, Twts) PI/NS5a pII completed enrollment, SVR12 poss at AASLD tho prob tight, read-thru to $ACHN (Msgs, Twts), catalyst for '14 vol http://t.co/aPmNFRJwH8

zbiotech via Twitter 10:08 AM  05/23/13 reply  |  re-tweet

$MRK (Msgs, Twts) PI/NS5a pII completed enrollment, SVR12 poss at AASLD tho prob tight, read-thru to $ACHN (Msgs, Twts), catalyst for '14 vol http://t.co/aPmNFRJwH8

sfef84 via Twitter 01:17 PM  05/22/13 reply  |  re-tweet

RT @AchillionPharma: Achillion presenting at UBS Healthcare Conf today at 3:30p ET live webcast here: http://t.co/oJ3YEQ5swu $ACHN (Msgs, Twts) #HCV

AchillionPharma via Twitter 03:21 PM  05/21/13 reply  |  re-tweet

Achillion presenting at UBS Healthcare Conf today at 3:30p ET live webcast here: http://t.co/oJ3YEQ5swu $ACHN (Msgs, Twts) #HCV

TurboResearch via Twitter 10:30 AM  05/21/13 reply  |  re-tweet

I need to do a write up on $APPY (Msgs, Twts) $ACHN (Msgs, Twts) $VICL (Msgs, Twts) trades soon.

Drew_Yoshida via Twitter 09:05 AM  05/20/13 reply  |  re-tweet

$ACHN (Msgs, Twts) - $7.85 SMA50 breakout on watch - Looking for continuation from Fridays EOD buying. Nice chart. $8.35 1st target -SMA200 & January low

Vin_Trader via Twitter 08:05 PM  05/19/13 reply  |  re-tweet

5/20 Stocks / $ACCO (Msgs, Twts) $ACHN (Msgs, Twts) $FOLD (Msgs, Twts) $FST (Msgs, Twts) $JE (Msgs, Twts) $PVA (Msgs, Twts) $RVLT (Msgs, Twts) - http://t.co/KtkDodGshi

Drew_Yoshida via Twitter 06:44 PM  05/19/13 reply  |  re-tweet

$END (Msgs, Twts), $IDIX (Msgs, Twts), $SKUL (Msgs, Twts), $MSPD (Msgs, Twts), $WTI (Msgs, Twts), $TXCC (Msgs, Twts), $ANTH (Msgs, Twts), $PVA (Msgs, Twts), $ATI (Msgs, Twts), $ZAZA (Msgs, Twts), $SFY (Msgs, Twts), $AMSC (Msgs, Twts), $FST (Msgs, Twts), $NOG (Msgs, Twts), $DGIT (Msgs, Twts), $ACHN (Msgs, Twts), $NOV (Msgs, Twts), $MNI (Msgs, Twts), $PWE (Msgs, Twts), $NOR (Msgs, Twts), $CPE (Msgs, Twts), $X (Msgs, Twts)

domainvc via Twitter 06:40 AM  05/18/13 reply  |  re-tweet

Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team $ACHN (Msgs, Twts) http://t.co/40WbynBKuF

sceenieweenie4l via Twitter 01:24 AM  05/18/13 reply  |  re-tweet

RT @crusadernz: BioPharmCatalyst updates http://t.co/1HlZfZlDUV $ACHN (Msgs, Twts) $BCRX (Msgs, Twts) $BLRX (Msgs, Twts) $CLVS (Msgs, Twts) $RIGL (Msgs, Twts) $INSM (Msgs, Twts) $TRGT (Msgs, Twts) $FLML (Msgs, Twts) $INFI (Msgs, Twts) $AEZS (Msgs, Twts) $SCMP (Msgs, Twts) $TSRX (Msgs, Twts) $KERX (Msgs, Twts) $ZIOP (Msgs, Twts) $ISIS (Msgs, Twts)

mcbio316 via Twitter 04:50 PM  05/17/13 reply  |  re-tweet

@JohnTuckerPhD @JasonCRG @chasingthealpha should add I'm skeptical $ACHN (Msgs, Twts) will get bought out as well

mcbio316 via Twitter 04:48 PM  05/17/13 reply  |  re-tweet

@JohnTuckerPhD @JasonCRG @chasingthealpha $ACHN (Msgs, Twts) not even involved in any collaborative trials w/nukes like a lot of the other key players

mcbio316 via Twitter 04:48 PM  05/17/13 reply  |  re-tweet

@JohnTuckerPhD @JasonCRG @chasingthealpha think $ACHN (Msgs, Twts) only hope is sum1 buys them out.otherwise w/o nuke think not in great shape in HCV mkt

JohnTuckerPhD via Twitter 04:26 PM  05/17/13 reply  |  re-tweet

@JasonCRG @chasingthealpha If they don't want to share revenues, that would probably be $ACHN (Msgs, Twts).

SPXKnight via Twitter 04:03 PM  05/17/13 reply  |  re-tweet

I am bullish two biotech tickers at the moment: $PCYC (Msgs, Twts) and $ACHN (Msgs, Twts). I will post charts later, but in short, both will retest their highs soon.

Pi_Shaped via Twitter 01:51 PM  05/17/13 reply  |  re-tweet

$ACHN (Msgs, Twts) dark horse in HCV treatment race - undervalued, imho

ethan780 via Twitter 01:43 PM  05/17/13 reply  |  re-tweet

RT @AndyBiotech: $ACHN (Msgs, Twts) is amending Ph2 combo study to include non-ribavirin arms & is in discussions w FDA to evaluate 8wk Rx in add. to 12wk Rx.(via BAML)

AndyBiotech via Twitter 01:43 PM  05/17/13 reply  |  re-tweet

$ACHN (Msgs, Twts) is amending Ph2 combo study to include non-ribavirin arms & is in discussions w FDA to evaluate 8wk Rx in add. to 12wk Rx.(via BAML)

SPXKnight via Twitter 01:01 PM  05/17/13 reply  |  re-tweet

$ACHN (Msgs, Twts) breaking out. 8's are coming. Usually I recommend $ACHN (Msgs, Twts) for shares-play only, but its options = cheap+playable now #biotech #breakout

C_S_1313 via Twitter 12:13 PM  05/17/13 reply  |  re-tweet

$ACHN (Msgs, Twts) still ticking up. stop gain raised $XNPT (Msgs, Twts) sold another 1/3 +$0.78 waiting for gap to get filled. holding the other 1/3 till

Pi_Shaped via Twitter 09:55 PM  05/16/13 reply  |  re-tweet

RT @zbiotech: $ACHN (Msgs, Twts) has amended/added 8 and 12wk regimens to all oral pII combo study, more potential data to look forward to late '13/early '14